Publicaciones en colaboración con investigadores/as de University of Genoa (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Longitudinal changes in patient-ventilator asynchronies and respiratory system mechanics before and after tracheostomy

    Respiratory Care, Vol. 66, Núm. 9, pp. 1389-1397

  3. The central nervous system during lung injury and mechanical ventilation: a narrative review

    British Journal of Anaesthesia, Vol. 127, Núm. 4, pp. 648-659

2019

  1. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

    Anesthesiology, Vol. 130, Núm. 2, pp. 263-283

2018

  1. NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

    Cancer Research, Vol. 78, Núm. 14, pp. 3913-3925

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

2016

  1. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

    Journal of Immunology Research, Vol. 2016

2012

  1. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites

    Digestive and Liver Disease, Vol. 44, Núm. 3, pp. 239-244

2010

  1. Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 6, pp. 2567-2574